Rapamycin With Grapefruit Juice for Advanced Malignancies
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Rapamycin With Grapefruit Juice for Advanced Malignancies is a clinical trial[1].
Key Facts
- Rapamycin With Grapefruit Juice for Advanced Malignancies is in the country of United States[2].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's instance of is recorded as clinical trial[3].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's start time is recorded as +2006-09-30T00:00:00Z[4].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's end time is recorded as +2009-05-31T00:00:00Z[5].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's sponsor is recorded as University of Chicago[6].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's main subject is recorded as benign pleural mesothelioma[7].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's main subject is recorded as BRCA1 hereditary breast and ovarian cancer syndrome[8].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's number of participants is recorded as {'unit': '1', 'amount': '+41'}[9].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's title is recorded as A Phase Ib Study Administering Rapamycin (Sirolimus) With Grapefruit Juice in Patients With Advanced Malignancies[10].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's ClinicalTrials.gov ID is recorded as NCT00375245[12].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's research intervention is recorded as sirolimus[13].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's research intervention is recorded as everolimus[14].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's clinical trial phase is recorded as phase I clinical trial[15].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's research site is recorded as University of Chicago[16].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's research subject recruitment status is recorded as completed[17].
- Rapamycin With Grapefruit Juice for Advanced Malignancies's study type is recorded as interventional study[18].